key: cord-0763722-cqdp81y9 authors: Seedat, S.; Chemaitelly, H.; Ayoub, H.; Makhoul, M.; Mumtaz, G. R.; Al Kanaani, Z.; Al Khal, A.; Al Kuwari, E.; Butt, A. A.; Coyle, P.; Jeremijenko, A.; Kaleeckal, A. H.; Latif, A. N.; Shaik, R. M.; Yassine, H. M.; Al Kuwari, M. G.; Al Romaihi, H. E.; Al-Thani, M. H.; Bertollini, R.; Abu-Raddad, L. J. title: SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates date: 2020-11-30 journal: nan DOI: 10.1101/2020.11.29.20240416 sha: 3f6ca6adbdbb4603b0f978a1d429597374efd4ea doc_id: 763722 cord_uid: cqdp81y9 Background: This study aimed to estimate the age-stratified and overall morbidity and mortality rates of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection based on an analysis of the pervasive SARS-CoV-2 epidemic in Qatar, a country with <9% of the population being [≥]50 years of age. Methods: Infection disease outcomes were investigated using a Bayesian approach applied to an age-structured mathematical model describing SARS-CoV-2 transmission and disease progression in the population. The model was fitted to infection and disease time-series and age-stratified data. Two separate criteria for classifying morbidity were used: one based on actual recorded hospital admission (acute-care or intensive-care-unit hospitalization) and one based on clinical presentation as per World Health Organization classification of disease severity or criticality. Results: All outcomes showed very strong age dependence, with low values for those <50 years of age, but rapidly growing rates for those [≥]50 years of age. The strong age dependence was particularly pronounced for infection criticality rate and infection fatality rate. Infection acute-care and intensive-care-unit bed hospitalization rates were estimated at 13.10 (95% CI: 12.82-13.24) and 1.60 (95% CI: 1.58-1.61) per 1,000 infections, respectively. Infection severity and criticality rates were estimated at 3.06 (95% CI: 3.01-3.10) and 0.68 (95% CI: 0.67-0.68) per 1,000 infections, respectively. Infection fatality rate was estimated at 1.85 (95% CI: 1.74-1.95) per 10,000 infections. Conclusions: SARS-CoV-2 severity and fatality in Qatar was not high and demonstrated a very strong age dependence with <4 infections in every 1,000 being severe or critical and <2 in every 10,000 being fatal. Epidemic expansion in nations with young populations may lead to lower disease burden than previously thought. The pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS- infection and associated Coronavirus Disease 2019 continue to be a global health challenge [1] . Aside from direct implications on morbidity and mortality [1], the pandemic led to severe economic and societal disruptions [2] , a consequence of the social and physical distancing restrictions imposed to slow SARS-CoV-2 transmission in view of its severity and fatality. Had infection severity and fatality been comparable to those of seasonal influenza or other common cold coronaviruses, such restrictions may not have been deemed necessary. One of the most affected countries by this pandemic is Qatar, a peninsula in the Arabian Gulf region with a population of 2.8 million [3, 4] . With its unique demographic and residential dwelling structure where 60% of the population are expatriate craft and manual workers (CMWs) living in large shared housing accommodations [3, 4] , Qatar experienced a pervasive epidemic with >60,000 laboratory-confirmed infections per million population as of November 23, 2020 [5, 6] . The epidemic grew rapidly starting from March 2020, peaked in late May 2020, then rapidly declined in subsequent weeks, and has been in a stable low-incidence phase now for four months ( Figure S1 of Supplementary Material (SM)). A series of serological studies completed by November 23, 2020 suggested that about half of the population have already been infected [5, [7] [8] [9] [10] . With a well-resourced public healthcare structure and a centralized and standardized data-capture system for all SARS-CoV-2 testing and COVID-19 care, Qatar has one of the most extensive databases to characterize this epidemic and its toll [5] . In addition to large-scale polymerase chain reaction (PCR) and serological testing, multiple population-based PCR and serological surveys have been conducted to date [5, [7] [8] [9] . As of November 23, 2020, cumulative overall 5 testing rates exceeded 638,000 per million population for PCR and 105,000 per million population for antibodies [11] . A comprehensive clinical characterization has also been completed for the hospitalized COVID-19 cases through individual chart reviews by trained medical personnel [11] , including infection severity classification as per the World Health Organization (WHO) guidelines [12] . Given the pervasive and advanced nature of the epidemic and availability of extensive epidemiological data, Qatar provides a unique opportunity to assess the extent of SARS-CoV-2 morbidity and fatality. We aimed in this study to estimate the age-stratified and overall infection acute-care and intensive-care-unit (ICU) hospitalization rates, infection severity and criticality rates, and infection fatality rate. Building on our previously developed SARS-CoV-2 models [5, [13] [14] [15] [16] [17] , an age-structured deterministic mathematical model was constructed to describe SARS-CoV-2 transmission dynamics and disease progression in the population ( Figure S2 of SM). Susceptible individuals in each age group were at risk of acquiring the infection based on their infectious contact rate per day, age-specific susceptibility to the infection, and an age-mixing matrix defining mixing between individuals in the different age groups. Following a latency period, infected individuals developed an infection that either did not require hospitalization, or that required hospitalization in an acute-care bed or in an ICU bed. Individuals admitted to an ICU bed had an additional risk for COVID-19 mortality. The model further included compartments tracking infection severity (asymptomatic/moderate/mild infection, severe infection, or critical infection as per WHO 6 severity classification) [12] . Population movement between model compartments was described using a set of coupled nonlinear differential equations (Text S1 of SM). The model was parameterized using best available data for SARS-CoV-2 natural history and epidemiology. Model parameters, definitions, and justifications can be found in Tables S1 and S2 of SM. The size and demographic structure of the population of Qatar were based on a population census conducted by Qatar's Planning and Statistics Authority [4] . The model was fitted to extensive time-series and age-stratified data for PCR laboratoryconfirmed infections, PCR testing positivity rate, antibody testing positivity rate, PCR and serological surveys, daily hospital admissions in acute-care and ICU beds, hospital occupancy in acute-care and ICU beds, incidence of severe and critical infections as per WHO classification [12] , and COVID-19 deaths (further details in Text S2 of SM). A Bayesian method, based on the incremental mixture importance sampling with shot-gun optimization [18, 19] , was used to fit the model to the different data sources and to estimate the mean and 95% credible interval (CI) for each estimated parameter (Text S2 of SM). The model was coded, fitted, and analyzed using MATLAB R2019a [20]. Table 1 provides a listing of each outcome measure estimated in this study, its definition, and its interpretation. Two sets of outcome measures were generated. The first set includes crude case rates, such as the crude case fatality rate, calculated as the cumulative number of a disease outcome (say COVID-19 death) over the cumulative number of documented (that is PCR laboratory-confirmed) infections. 7 The second set includes infection rates, such as the infection fatality rate, calculated as the cumulative number of a disease outcome (say COVID-19 death) over the model-estimated cumulative number of infections, documented and undocumented. Two separate criteria for classifying morbidity were used: one based on actual recorded hospital admission (acute-care or ICU) and one based on clinical presentation as per WHO classification of disease severity [12] . While the two are overlapping with severe cases typically admitted to acute-care beds, and critically ill cases admitted to ICU beds, a significant fraction of mild or moderately ill cases were hospitalized out of caution. Moreover, hospitalization was used as a form of case isolation earlier in the epidemic. Of note that the health system in Qatar remained well within its threshold even at the epidemic peak towards end of May 2020. Figure 1A shows the crude case acute-care and ICU bed hospitalization rate versus time. The rate was rather stable, but with a slightly declining trend, and was assessed at 113.9 acute-care and/or ICU hospital admissions per 1,000 laboratory-confirmed infections on November 22, 2020. As of this date, a total of 18,509 acute-care and 1,759 ICU hospital admissions had been registered. Figure 1B shows the crude case severity and criticality rate versus time. The rate was rather stable, but with a slightly declining trend, and was assessed at 28.0 severe and/or critical cases per 1,000 laboratory-confirmed infections on November 22, 2020. As of this date, a total of 4,127 severe and 863 critical infections had been registered. Figure 1C shows the crude case fatality rate versus time. The rate increased over time, as expected with the weeks-long delay between infection and eventual COVID-19 death, but then 8 stabilized as the epidemic entered its low but stable infection incidence phase ( Figure S1 of SM). The rate was assessed at 13.2 deaths per 10,000 laboratory-confirmed infections on November 22, 2020. As of this date, a total of 235 COVID-19 deaths had been registered. The model produced robust fits to each dataset. Table S3 of SM summarizes the goodness-of-fit. Figure 2 , and Figure 3A show the estimated mean and 95% CI of all age-specific infection rate measures. All rates showed very strong age dependence. Measures increased steadily with age, with low values for those <50 years of age, but very rapidly growing rates for those ≥50 years of age. The strong age dependence was even more pronounced for infection ICU bed hospitalization rate ( Figure 2B ), infection criticality rate ( Figure 2D ), and infection fatality rate ( Figure 3A ). The overall (total population of all age groups) infection acute-care bed hospitalization rate was estimated at 13.10 (95% CI: 12.82-13.24) per 1,000 infections, infection ICU bed hospitalization rate at 1.60 (95% CI: 1.58-1.61) per 1,000 infections, infection severity rate at 3.06 (95% CI: 3.01-3.10) per 1,000 infections, infection criticality rate at 0.68 (95% CI: 0.67-0.68) per 1,000 infections, and infection fatality rate at 1.85 (95% CI: 1.74-1.95) per 10,000 infections. 9 Figure 1D shows the infection acute-care and ICU bed hospitalization rate versus time. The rate increased over time, as expected with the delay between infection and hospital admission, but then stabilized ( Figure 1D ) as the epidemic peaked and started to decline ( Figure S1 of SM). The rate was assessed at 13.8 hospital admissions per 1,000 infections on November 22, 2020. A similar pattern was found for the infection severity and criticality rate ( Figure 1E ) and infection fatality rate ( Figure 1F ), which were assessed at 3.4 cases per 1,000 infections and 1.6 deaths per 10,000 infections, respectively, on November 22, 2020. The study generated other relevant estimates. The diagnosis (detection) rate as of November 22, 2020 , that is the proportion of infections that were documented (with PCR laboratory-confirmed diagnosis) out of all infections that were estimated to have occurred, was assessed at 12.1% (95% CI: 12.0-12.1%). The mean duration of acute-care hospitalization was estimated at 8.73 (95% CI: 8.62-8.83) days and the mean duration of ICU hospitalization was estimated at 12.30 (95% CI: 12.18-12.41) days. The striking finding of this study is that SARS-CoV-2 morbidity and mortality demonstrated a very strong age dependence. Infection severity, criticality, and fatality increased very rapidly with age. This was particularly the case for infection criticality and fatality which were limited for those <50 years of age but increased very rapidly for those ≥50 years of age (Figures 2-3 ). This strong age dependence combined with the lower infection exposure in those ≥60 years of age ( Figure S10 of SM) and the small proportion of the population ≥50 years of age (9%) and ≥60 years of age (2%), all contributed together to a low morbidity and mortality in Qatar. Out of every 1,000 infections, only 3.7 infections were destined to be severe or critical, and out of every 10,000 infections, only 1.9 infections were destined to end in COVID-19 death ( Table 2 ). All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. ; https://doi.org/10.1101/2020.11.29.20240416 doi: medRxiv preprint Notably, both SARS-CoV-2 morbidity and mortality in Qatar were not much higher than those typically seen in a seasonal influenza epidemic in the United States [21, 22] . This fact, however, needs to be interpreted in context. With the young age structure of the population in Qatar, a seasonal influenza epidemic in this country has a much lower severity than that in the United States. Typically, only a handful of influenza-related deaths are reported every year in Qatar [23] . Other lines of evidence support these findings. In a survey of ten CMW communities in Qatar, only five severe infections and one critical infection ever occurred in 3,233 persons with confirmed infection (antibody and/or PCR positive result), that is an infection severity and criticality rate of 2.5 (95% CI: 1.1-4.9) per 1,000 infections [7] . In another nationwide survey of the CMW population, only seven severe infections and one critical infection ever occurred in 1,590 persons with antibody and/or PCR positive result, an infection severity and criticality rate of 5.0 (95% CI: 2.2-9.9) per 1,000 infections [8] . Both of these estimates are in agreement with the present study estimate of 3.7 (95% CI: 3.7-3.8) per 1,000 infections. These figures, however, are substantially lower than those estimated elsewhere, often using early epidemic data [24] [25] [26] [27] [28] [29] . The fact that the early phases of the epidemic in Europe and the United States heavily affected nursing facilities and care homes of the elderly may have biased the estimates to higher values. It is also possible that our estimates are lower because of the robust accounting of the large pool of undocumented infections in the present study, thanks to the series of serological surveys conducted in Qatar [5, [7] [8] [9] [10] . These surveys provided some of the key input data for this modeling study. For instance, the nationwide survey of the CMW population found that only 9.3% (95% CI: 7.9-11.0%) of those antibody positive had a prior documented PCR laboratory-confirmed infection [8] . This is in agreement with the diagnosis (detection) rate All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. estimated here at 12.1% (95% CI: 12.0-12.1%), as well as growing evidence from other countries indicating that only one in every 10 infections was ever diagnosed [24, [30] [31] [32] [33] . The totality of evidence on the Qatar epidemic also indicates that most infections were asymptomatic or minimally mild to be diagnosed [5] [6] [7] [8] [9] [34] [35] [36] . For instance, a national SARS-CoV-2 PCR survey found that 58.5% of those testing PCR positive reported no symptoms within the preceding two weeks of the survey [5] . In light of these findings, it is evident that the strong age dependence of SARS-CoV-2 morbidity and mortality is a principal contributor to the low morbidity and mortality seen in Qatar compared to elsewhere. The impact of this strong age dependence is illustrated in Figure 3B where the age-specific infection fatality rate of Table 2 has been applied to the age structure of other national populations. The infection fatality rate in Italy was found to be 10-fold higher than that in Qatar, only because of the population's different age structure. These findings indicate that the infection morbidity and mortality may vary immensely across countries, and will be substantially lower in countries with younger demographic structures, as suggested earlier [13] . While age appears to be the principal factor, other factors could have also contributed to explaining the low morbidity and mortality in Qatar. Growing evidence indicates T cell and antibody reactivity against SARS-CoV-2 in unexposed individuals [37] [38] [39] [40] , that probably reflects development of T cell and antibody immune memory to circulating 'common cold' coronaviruses, which may have in turn led to lower morbidity and mortality [37] [38] [39] [40] . The sharedhousing dwelling structure in Qatar that contributed to the large SARS-CoV-2 epidemic [5] may have, along with the frequent international travel of Qatar's expatriate population, also contributed to higher levels of exposure to other common cold coronaviruses [41, 42] , thereby inducing high levels of broadly cross-reactive T cell and antibody responses. Such pre-existing All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. ; 12 immune reactivity [37] [38] [39] [40] may have thus resulted in lower levels of SARS-CoV-2 morbidity and mortality in the population of Qatar. The resourced healthcare system, which was well below its threshold even at the epidemic peak, may have also contributed to the low observed morbidity and mortality. Emphasis on proactive early treatment, in addition to a cautious approach for SARS-CoV-2 case management, may have limited the number of people who went on to require hospitalization, or to develop severe or critical disease. Limitations may have affected this study. We estimated rates of infection morbidity and mortality, not accounting for potential differences by sex, comorbidities, or other factors. Model estimations are contingent on the validity and generalizability of input data. Available input data were most complete at the national level, and although there could be subpopulation differences in the highly diverse population of Qatar, these could not be factored in the model given insufficient data at the subpopulation level. Despite these limitations, our model, tailored to the complexity of the epidemic in Qatar, was able to reproduce the observed epidemic trends, and provided profound insights about healthcare needs and infection morbidity and mortality. In conclusion, SARS-CoV-2 morbidity and mortality demonstrate a strikingly strong age dependence. With its young population structure, both morbidity and mortality were low in Qatar, and not much higher than those typically seen in a seasonal influenza epidemic in the United States [21, 22] . Out of every 1,000 infections, only 3.7 infections were severe or critical, and out of every 10,000 infections, only 1.9 infections were fatal. However, these rates would have been much higher if the population of Qatar had a similar demographic structure to that found in Europe or the United States. These findings suggest that SARS-CoV-2 morbidity and All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. ; https://doi.org/10.1101/2020.11.29.20240416 doi: medRxiv preprint 13 mortality may vary immensely by country or region, and that the pandemic expansion in nations with young populations may lead to much milder disease burden than currently believed. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. ; Classification of infection severity and criticality was per WHO infection severity classification [12] . All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. ; https://doi.org/10.1101/2020.11.29.20240416 doi: medRxiv preprint Table 2 . Estimated mean and 95% credible interval (CI) of the age-specific infection acute-care and ICU bed hospitalization rates, infection severity and criticality rates, and infection fatality rate. Classification of infection severity and criticality was per WHO infection severity classification [12] . All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. ; Figure 3 . A) The age-specific infection fatality rate in Qatar. B) Estimated overall (total population of all age groups) infection fatality rate for several select countries that are characterized by diverse demographic structures. The estimates were generated by applying the Qatar-estimated age-specific infection fatality rate to the age structure of the population in each country. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. ; https://doi.org/10.1101/2020.11.29.20240416 doi: medRxiv preprint LJA conceived and designed the study and led the mathematical modeling and statistical analyses and writing of the manuscript. SS co-constructed and parameterized the mathematical model, conducted the mathematical modeling analyses, and co-wrote the first draft of the manuscript. HC contributed to the parameterization of the mathematical model, conducted the statistical analyses, and co-wrote the first draft of the manuscript. HHA co-constructed and parameterized the mathematical model. All authors contributed to data collection and acquisition, database development, discussion and interpretation of the results, and to the writing of the manuscript. All authors have read and approved the final manuscript. We declare no competing interests. We thank Her Excellency Dr. Hanan Al Kuwari, Minister of Public Health, for her vision, guidance, leadership, and support. We also thank Dr. Saad Al Kaabi, Chair of the System Wide Incident Command and Control (SWICC) Committee for the COVID-19 national healthcare response, for his leadership, analytical insights, and for his instrumental role in enacting data information systems that made these studies possible. We further extend our appreciation to the SWICC Committee and the Scientific Reference and Research Taskforce (SRRT) members for their informative input, scientific technical advice, and enriching discussions. We also thank Dr. Mariam Abdulmalik, CEO of the Primary Health Care Corporation and the Chairperson of the Tactical Community Command Group on COVID-19, as well as members of this committee, for providing support to the teams that worked on the field surveillance. We further thank Dr. Nahla All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. ; https://doi.org/10.1101/2020.11.29.20240416 doi: medRxiv preprint Figure S1 . Time course of the SARS-CoV-2 epidemic in Qatar. Daily incidence of (A) documented laboratory-confirmed infections and (B) documented and undocumented infections estimated by the model. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. ; https://doi.org/10.1101/2020.11.29.20240416 doi: medRxiv preprint 3 Text S1. Mathematical model structure and description We constructed an age-structured deterministic mathematical model to describe the severe acute Epidemic dynamics were described using age-specific sets of coupled nonlinear differential equations. Each age group, a , denoted a ten-year age band apart from the last category which grouped together all individuals ≥80 years of age. Qatar's population size and demographic structure were based on findings of "The Simplified Census of Population, Housing, and Establishments" conducted by Qatar's Planning and Statistics Authority [6] . Life expectancy was obtained from the United Nations World Population Prospects database [7] . All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. ; https://doi.org/10.1101/2020.11.29.20240416 doi: medRxiv preprint Figure S2 . Schematic diagram describing the basic structure of the SARS-CoV-2 mathematical model and its associated tracking compartments. The following equations were used to describe the transmission dynamics in the total population: Table S1 . All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. ; https://doi.org/10.1101/2020.11.29.20240416 doi: medRxiv preprint 6 Table S1 . Definitions of population variables and symbols used in the model. Definition Latently infected population ( ) Population that is infectious but with an infection that will not require hospitalization ( ) Ia − Population that is infectious and that will progress to acute-care hospitalization ( ) Population that is infectious and that will progress to ICU hospitalization ( ) 1 Age e = , the mixing is fully assortative, that is individuals mix only with members in their own age group. Model input parameters were based on best available empirical data for SARS-CoV-2 natural history and epidemiology. Model input parameter values and supporting evidence are listed in Table S2 . Based on existing estimate [8] and based on observed time to recovery among persons with mild infection [8, 12] and observed viral load in infected persons [10, 11, 13] Life expectancy in Qatar 1/  80.7 years United Nations World Population Prospects database [7] The model was fitted to extensive sources of data thanks to the centralized and standardized fraction of individuals admitted to ICU beds from acute-care beds, 10) time-series of current All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. A Bayesian method, based on incremental mixture importance sampling with shotgun optimization [14, 15] , was used to conduct the model fitting and generate posteriors and credible sets. In the first stage (initialization), the importance sampling distribution was initialized by drawing a large number of points from the prior distribution and weights were attached to each point using their respective log-likelihood. In the second stage (shot-gun optimization), multiple sequential optimizations were carried out. In each of these, the point of the importance sampling distribution with the maximum weight was computed, and a new sample set was drawn from a Gaussian distribution centered at this point. The local maximum of this sample set (point with largest log-likelihood) was then identified. The importance sampling distribution was then updated to exclude the points that are farthest from this local maximum in terms of Mahalanobis distance. A new sample set was then drawn from a Gaussian distribution centered at the current local maximum and was added to the importance sampling distribution. At the end of the shot-gun optimization stage, a candidate importance sampling distribution was obtained. In the third stage (importance sampling), weights were attached to each point in the importance sampling distribution and sampling was iterated until convergence in the distribution of the importance sampling distribution. In the fourth stage (resampling), points were resampled from the importance sampling distribution to construct the posterior distribution of each estimated parameter. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. Figure S3 . Posterior distribution of the age-specific infection acute-care bed hospitalization rate. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. ; https://doi.org/10.1101/2020.11.29.20240416 doi: medRxiv preprint Figure S4 . Posterior distribution of the age-specific infection ICU bed hospitalization rate. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. ; https://doi.org/10.1101/2020.11.29.20240416 doi: medRxiv preprint Figure S5 . Posterior distribution of the age-specific infection severity rate. Classification of infection severity was per WHO severity classification [1]. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. ; https://doi.org/10.1101/2020.11.29.20240416 doi: medRxiv preprint Figure S6 . Posterior distribution of the age-specific infection criticality rate. Classification of infection criticality was per WHO severity classification [1]. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. ; https://doi.org/10.1101/2020.11.29.20240416 doi: medRxiv preprint 15 Figure S7 . Posterior distribution of the age-specific infection fatality rate. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. ; https://doi.org/10.1101/2020.11.29.20240416 doi: medRxiv preprint Figure S8 . Posterior distribution of the overall (total population of all age groups) A) infection acute-care bed hospitalization rate, B) infection ICU bed hospitalization rate, C) infection severity rate, and D) infection criticality rate. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. ; https://doi.org/10.1101/2020.11.29.20240416 doi: medRxiv preprint Figure S9 . Posterior distribution of the overall (total population of all age groups) infection fatality rate. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. ; https://doi.org/10.1101/2020.11.29.20240416 doi: medRxiv preprint Figure S10 . The SARS-CoV-2 age-specific antibody prevalence (seroprevalence) in the total population of Qatar based on compilation and analysis of seroprevalence data from a series of serological studies [3, [16] [17] [18] [19] . All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 30, 2020. ; The global macroeconomic impacts of COVID-19: seven scenarios The Simplified Census of Population, Housing & Establishments Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar Evidence for and level of herd immunity against SARS-CoV-2 infection: the ten-community study Seroprevalence of SARS-CoV-2 infection in the craft and manual worker population of Qatar Seroprevalence of SARS-CoV-2 infection in the urban population of Qatar Link between PCR positivity and antibody positivity for SARS-CoV-2 infection: analyses of a database of 9 National SARS-CoV-2 PCR and antibody testing, infection severity, and hospitalization database. 2020. 12. World Health Organization. Clinical management of COVID-19 Age could be driving variable SARS-CoV-2 epidemic trajectories worldwide Characterizing key attributes of the epidemiology of COVID-19 in China: Model-based estimations Epidemiological impact of SARS-CoV-2 vaccination: Mathematical modeling analyses Analyzing inherent biases in SARS-CoV-2 PCR and serological epidemiologic metrics Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to Estimating and projecting trends in HIV/AIDS generalized epidemics using incremental mixture importance sampling Incremental Mixture Importance Sampling With Shotgun Optimization Estimating influenza disease burden from population-based surveillance data in the United States Systematic Assessment of Multiple Routine and Near Real-Time Indicators to Classify the Severity of Influenza Seasons and Pandemics in the United States Influenza morbidity and mortality in the State of Qatar The infection fatality rate of COVID-19 inferred from seroprevalence data A systematic review and meta-analysis of published research data on COVID-19 infection-fatality rates Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe Estimating the burden of SARS-CoV-2 in France Estimates of the severity of coronavirus disease 2019: a model-based analysis Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States Substantial underestimation of SARS-CoV-2 infection in the United States Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study Hospital admission rates, length of stay, and in-hospital mortality for common acute care conditions in COVID-19 vs. pre-COVID-19 era Pre-existing immunity to SARS-CoV-2: the knowns and unknowns Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome Preexisting and de novo humoral immunity to SARS-CoV-2 in humans Comparative Serological Study for the Prevalence of Anti-MERS Coronavirus Antibodies in High-and Low-Risk Groups in Qatar Endemic human coronaviruses induce distinct antibody repertoires in adults and children Age could be driving variable SARS-CoV-2 epidemic trajectories worldwide Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to Characterizing key attributes of the epidemiology of COVID-19 in China: Model-based estimations The Simplified Census of Population, Housing & Establishments United Nations Department of Economic and Social Affairs Population Dynamics. The 2019 Revision of World Population Prospects Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2) The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Available from Temporal dynamics in viral shedding and transmissibility of COVID-19 Estimating and projecting trends in HIV/AIDS generalized epidemics using incremental mixture importance sampling Incremental Mixture Importance Sampling With Shotgun Optimization Evidence for and level of herd immunity against SARS-CoV-2 infection: the ten-community study Seroprevalence of SARS-CoV-2 infection in the craft and manual worker population of Qatar Seroprevalence of SARS-CoV-2 infection in the urban population of Qatar Link between PCR positivity and antibody positivity for SARS-CoV-2 infection: analyses of a database of 9 The force of infection (hazard rate of infection) experienced by each susceptible population, () Sa, is given by Care ICU a NoH Acute Care ICU Acute Care ICU I a I a I a a t a S a E a I a I a I a H a H Here 1 a , 2 a , 1 b , 2 b , 1 c , and 2 c are fitting parameters.The probability that an individual in the a age group will mix with an individual in the a age group is determined by an age-mixing matrix,